Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.
about
Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients.Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysisPharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.Low Caspofungin Exposure in Patients in Intensive Care Units.Invasive aspergillosis: resistance to antifungal drugs.Safety and interactions of new antifungals in stem cell transplant recipients.The Eagle-like effect of echinocandins: what's in a name?High-dose caspofungin as a component of combination antifungal therapy in 91 patients with neoplastic diseases and hematopoietic stem cell transplantation: a critical review of short-term and long-term adverse events.Sources of preanalytical error in pharmacokinetic analyses - focus on intravenous drug administration and collection of blood samples.Impact of special patient populations on the pharmacokinetics of echinocandins.An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.Echinocandins in antifungal pharmacotherapy.Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxisUptake and efflux kinetics, and intracellular activity of voriconazole against Aspergillus fumigatus in human pulmonary epithelial cells: a new application for the prophylaxis and early treatment of invasive pulmonary aspergillosis.Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.Physiology-based pharmacokinetics of caspofungin for adults and paediatrics.A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.Invasive Aspergillosis in Children: Update on Current Guidelines
P2860
Q35666527-788B2F4E-DD98-4405-A640-F219BEA92589Q35680443-EC04031C-59A4-455F-9FE1-1DB85550746AQ36285521-33806BF0-EE7C-481B-9C25-D062107AEF43Q37247452-5FEB4987-1E07-40AC-9134-FC6E32BEAB3BQ37612914-49C3A8DF-85D1-41A9-966D-9A48541DDD37Q37983464-62641D8B-8242-4F2D-AD9B-91A8FED4C3E6Q38036740-80F709CE-D6BC-4C23-953D-7C948CA7AB40Q38153458-34FF3DD3-F359-4F99-A04C-7E5A21B3F6A4Q38173720-47DEA4EC-FF45-4DBB-A75B-1C6A21D3D357Q38205047-FEB00943-28E6-466A-8B30-D62C8FD657D7Q38462784-DA17D51F-5774-4593-8307-B420E6B14B40Q39048531-7B8D8700-D207-4BFF-BC45-8EB27302BE10Q39458862-A686C16F-2ABB-487F-9702-159BD495E3EAQ39471624-4C7D811A-AE88-49A9-9A8F-3DB129204ADEQ40396776-8ABB7D5C-89DA-4F38-9981-06203BFAB1F2Q41580172-55731F63-88B3-4440-8867-A580DE8E10F6Q41671785-56FC241A-27C1-4031-8A1C-4E373E571210Q55479804-E145E5D0-88F6-4852-A3BC-323847BB72C0Q58775551-F745D440-8851-4DB3-BA11-72D5EDC6A6AD
P2860
Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Randomized comparison of safet ...... opoietic stem cell recipients.
@ast
Randomized comparison of safet ...... opoietic stem cell recipients.
@en
Randomized comparison of safet ...... opoietic stem cell recipients.
@nl
type
label
Randomized comparison of safet ...... opoietic stem cell recipients.
@ast
Randomized comparison of safet ...... opoietic stem cell recipients.
@en
Randomized comparison of safet ...... opoietic stem cell recipients.
@nl
prefLabel
Randomized comparison of safet ...... opoietic stem cell recipients.
@ast
Randomized comparison of safet ...... opoietic stem cell recipients.
@en
Randomized comparison of safet ...... opoietic stem cell recipients.
@nl
P2093
P2860
P356
P1476
Randomized comparison of safet ...... topoietic stem cell recipients
@en
P2093
Andreas H Groll
Charlotte Young
Claudia Lanvers-Kaminsky
Gerda Silling
Gudrun Wuerthwein
Hedwig Kolve
Helmut Ostermann
Joachim Gerss
João Paulo Vieira Pinheiro
Rainer Schwerdtfeger
P2860
P304
P356
10.1128/AAC.00425-10
P407
P577
2010-07-26T00:00:00Z